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Dendritic Ligands for Magnetic Suspensions in Liquid Crystals
Martin Hähsler[a,b] and Silke Behrens*[a,b]
Abstract: The synthesis of long-chain, aliphatic and space fill-
ing dendritic ligands containing (pro)mesogenic, aliphatic or
nitrile biphenyl moieties for the stabilization of magnetic nano-
particles in liquid crystal hosts is described. A Negishi or Sono-
gashira cross-coupling is exploited as a key step in the synthetic
sequence. These synthetic procedures enable the synthesis of
various ligands which can be easily adapted to different types
of liquid crystals [e.g. 4-pentyl-4′-cyanobiphenyl (5CB)]. For in-
Introduction
Suspensions of magnetic nanoparticles (MNPs) in liquid crystals
(LCs) combine physical properties of both materials. These
properties of the hybrid materials include electro-optical, mag-
neto-optical (static and dynamic) and magneto-rheological
properties not observed for the individual components.[1] In
1970, Brochard and de Gennes suggested that doping of LCs
with shape-anisotropic MNPs leads to an increase in magnetic
susceptibility .[2] For the first time, the macroscopic collective
behavior of ferromagnetic γ-Fe2O3 nanorods (500 × 70 nm) in
N-(4-methoxy-benzylidene)-4-butylaniline (MBBA, Figure 1) was
then demonstrated experimentally by Amer et al. in 1983.[3] In
2013, a ferromagnetic nematic phase with spontaneous magne-
tization was realized by Mertelj et al. embedding ferromagnetic
BaFe11.5Sc0.5O19 nanodiscs (70 × 5 nm) in 4-pentyl-4′-cyanobi-
phenyl (5CB, Figure 1).[4]
Despite the great interest in colloidal suspensions of MNPs
in LCs, applications have been mainly hampered by a relatively
low colloidal stability and a strong tendency to form aggre-
gates. Examples in the literature have reported on the forma-
tion of aggregates [in particular for high particle concentrations
(> 0.01 wt.-%)] leading to inhomogeneous particle distribution
or even macroscopic phase separation.[5] Phase separation is
caused by gravitational forces, magnetic field gradients and
coagulation of solid particles due to elastic LC, van der Waals
[a] Karlsruhe Institute of
Technology, Institute of Catalysis Research and Technology
Hermann-von-Helmholtz-Platz 1, 76344 Karlsruhe, Germany
E-mail: silke.behrens@kit.edu
https://www.ikft.kit.edu/263.php
[b] Heidelberg University, Institute of Inorganic Chemistry
Im Neuenheimer Feld 270, 69120 Heidelberg, Germany
Supporting information and ORCID(s) from the author(s) for this article are
available on the WWW under https://doi.org/10.1002/ejoc.201901450.
© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. ·
This is an open access article under the terms of the Creative Commons
Attribution License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
Eur. J. Org. Chem. 2019, 7820–7830 © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim7820
stance, a three-step sequence (i.e. etherfication, Sonogashira–
Hagihara cross-coupling and Steglich-esterfication) yields a
dendritic ligand in 77 % overall yield starting from literature
known compounds. The length of the ligand is important to
stabilize the magnetic nanoparticles, and, therefore, the length
of the ligand may be easily modified by this approach. Indeed,
the established synthesis can readily tackle this issue.
Figure 1. Aliphatic ligand 1 and dendritic ligand 2 are structurally highly-
adapted to different liquid crystals e.g. MBBA, 5CB and 8OCB.
and/or magnetic dipole-dipole interactions. Lower particle con-
centrations minimize potential interactions and thus the num-
ber and size of aggregates.[3,4] In order to prevent particle
aggregation and phase separation, specific (pro)mesogenic li-
gands have been introduced to functionalize the particle sur-
face.
The role of these (pro)mesogenic ligands is not only the
steric repulsion by a large exclusion volume, but also the
“smoothing out” of the disturbance of the local LC director
caused by the nanoparticles (especially at the MNP-LC inter-
face).[6] Therefore, it is no coincidence that the most stable col-
loidal LCs have been obtained either with ligands bearing me-
sogenic entities or a combination of (pro)mesogenic and ali-
phatic ligands. Ligands exploited for the stabilization of nano-
particles in LCs are typically composed of three major structural
parts: a) an anchoring group (e.g., carboxyl, phosphates and
amines), b) an aliphatic linker/spacer connecting the binding
group with c) the (pro)mesogenic unit. The choice of the
(pro)mesogenic unit depends on the LC and may consist, e.g.,
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of a biphenyl residue bearing either a nitrile or an octyloxy end
group in case of 8OCB, respectively (Figure 1).
The functionalization of magnetic nanorods with an octyl-
oxybiphenyl-based ligand, for example, was shown to signifi-
cantly reduce aggregation, as compared to their oleic acid-
coated counterparts.[7] Likewise a ligand consisting of a 4-
cyanobiphenyl residue and an aliphatic C7- or C15-spacer, re-
spectively, was previously demonstrated to stabilize 2.5 nm size
CoFe2O4 MNPs in 5CB.[8] Increasing the linker length from C7 to
C15, lead to a larger exclusion volume and thus to better steric
stabilization and allowed for the stabilization of higher MNP
concentrations in the LC (i.e. without macroscopic aggregation
in an external magnetic field). This suggests that a longer ali-
phatic spacer may allow for the stabilization of larger MNPs or
achieving higher MNP concentrations. If the MNPs are intro-
duced into the LC, the mutual molecular alignment not only
disturbs the local LC order in the vicinity of the MNPs, but also
disturbs the originally isotropic, (pro)mesogenic ligand shell of
the MNP from spherical to tactoidal, which can also lead to
MNP agglomeration.[9]
Dendritic ligands with a tree-like architecture may tackle this
problem of equatorial ligand depletion on the nanoparticle sur-
face. Dermortière et al. have reported on the functionalization
of MNPs with a dendritic ligand which leads to the formation
of a magnetic hybrid material with birefringent, optical proper-
ties.[10] Yet, the stabilization of the MNPs in a LC host was not
investigated. Vashchenko et al. have reported a seven-step syn-
thesis for dendritic ligands with different mesogenic units and
end groups, respectively; however, the overall yield of this pro-
cedure was poor (i.e. 9–17 %).[11] The corresponding dendritic
ligands based on 4′-octyloxy-biphenyl end groups were em-
ployed for the stabilization of 7.8 nm size CoFe2O4 MNPs.[5b]
High particle concentrations (i.e. 1 wt.-%) were achieved while
relatively few aggregates were formed.
Despite the successful stabilization of nanoparticles in LCs
by (pro)mesogenic ligands with a linear or dendritic structure,
their preparation typically requires multi-step synthesis meth-
ods that are complicated, deliver only small amounts of the
target ligand and thus limit the overall application. Hence, it
is not only important to design organic ligands with specific
structures, topologies and properties but also to develop syn-
thetic procedures that are both simple and versatile at the same
time. Herein, we describe a practical approach for the synthesis
of (pro)mesogenic ligands with linear and dendritic structures
and compare alternative approaches. We address the spacer
length and the space-filling nature of these ligands. The syn-
thetic procedures described herein range from the synthesis of
the linear ligand 1 to the simple, three-step synthesis of the
dendritic ligand 2 with an overall yield of 77 % (Figure 1).
Results and Discussion
Linear (pro)mesogenic ligands
The aliphatic ligand 1 exhibiting a (pro)mesogenic octyl-bi-
phenyl structural motif was obtained from iodide 3 in a three-
step synthetic procedure (Scheme 1). The octyl group was intro-
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duced via a Sonogashira cross-coupling reaction, yielding alk-
yne 4 in 90 % yield after column chromatography.[12] Subse-
quently, the Pd-catalyzed hydrogenation of the triple bond in
4 led to alcohol 5.[13] Eventually, the alcohol 5 and the commer-
cial bromide 6 were treated with NaH. Since the alcoholate of
5 showed a poor solubility, tetrabutylammonium sulfate was
employed as phase transfer agent. Nucleophilic substitution
gave ligand 1 in an overall yield of 69 %.[8]
Scheme 1. Synthesis of aliphatic ligand 1: i.) Sonogashira cross-coupling of
iodide 3 and oct-1-yne, ii.) Pd-catalyzed reduction with hydrogen of the triple
bond of alkyne 4, and iii.) etherification of alcohol 5 and bromide 6.
Long-chain ligands (n > 15) via Negishi cross-coupling
As mentioned earlier, the length of the aliphatic spacer influen-
ces nanoparticle stabilization, and the increase in chain length
allows for stabilization of higher particle concentrations.[8] How-
ever, the etherification described in Scheme 1 is limited to
n-bromocarbonic acids. As the chain length of the n-bromo-
carbonic acids increases, the solubility in common organic sol-
vents decreases. Therefore, an alternative synthetic pathway is
required to build up ligands with longer alkyl spacers
[(–CH2–)n; n > 15]. Here, a C(sp3)–C(sp3)-Negishi cross-coupling
of the corresponding methyl ester was employed to synthesize
ligands with a spacer length of n = 17, 25.[14] First, as described
earlier for bromide 9c, a modified procedure of a Mitsunobu
reaction of alcohol 4 and 5, and 11-bromoundecan-1-ol (8) with
diisopropyl azodicarboxylate (DIAD) gave bromide 9a and 9c in
87 % and 94 % yield, respectively (Scheme 2).[10]
Scheme 2. Mitsunobu reaction of DIAD, 11-bromoundecan-1-ol (8) and alco-
hol 4, 5 and 7, respectively.
Then, 9c was treated with the commercial compound 10a
via C(sp3)–C(sp3)-Negishi cross-coupling to form the long-chain
aliphatic ester 11a (Scheme 3). Compound 10b was obtained
as a colorless solid (99 %) from the corresponding carbonic acid
in a mixture of methanol with a catalytic amount of H2SO4.[15]
Using the same reaction conditions in the Negishi cross-cou-
pling, bromide 9c and compound 10b resulted in the formation
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of the poorly soluble ester 11b. Thus, ester 11b could only
be assigned with a 1H NMR experiment not with a 13C NMR
experiment.
Scheme 3. Synthesis sequence for the preparation of long-chain aliphatic
esters 11a and 11b.
The poor solubility of the esters 11a and 11b made their
transesterification even more difficult and attempts to depro-
tect them with TFA or LiOH in THF/MeOH (1:1) led to a precipi-
tate. These precipitates were insoluble in common organic sol-
vents (halogenated solvents, DMSO, DMF etc.). Hence, they
could neither be further characterized nor directly exploited as
ligands in the stabilization of magnetic nanoparticles. In order
to overcome the issue of poor ligand solubility while maintain-
ing large exclusion volumes of the ligands, a protocol for den-
dritic ligands was established in the following using a Sonoga-
shira cross-coupling.
Synthesis of dendritic (pro)mesogenic ligands
A terminal anchoring group of the (pro)mesogenic ligand binds
to the nanoparticle surface. Thereby, the binding efficiency de-
pends strongly on both the type of anchoring group and the
inorganic core. Several types of anchoring groups (e.g., carb-
oxyl, amine) have been employed to directly bind organic
ligands to the inorganic core of Co, CoFe2O4 or Fe3O4 nanoparti-
cles, respectively. Alternatively, functional groups such as,
hydroxyl,[16] alkenyl,[17] alkynyll[18] may be employed for cova-
lent coupling to polymer-coated MNPs. In order to enable the
functionalization of different types of nanoparticles with
(pro)mesogenic ligands, we aimed for a scalable and variable
method for a broad application spectrum and a high tolerance
for functional groups. Therefore, a Sonogashira cross-coupling
was investigated as a key step in the synthetic sequence of the
(pro)mesogenic ligands.[12]
Triols 12a and 12b were obtained via deprotection of the
corresponding methoxy derivatives with BBr3 (Table 1).[19]
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Those triols were further reacted with bromide 9a, 9b and 9c,
respectively, under reflux in a suspension of anhydrous acetone
and K2CO3 under inert conditions (Table 1).[10] In the case of
iodide 13d the yield could be increased by roughly 10 % via
exclusion of light.
Table 1. Results of the etherification of triol 12a and 12b and bromides 9a,
9b, 9c. Yields were determined after column chromatography.
Dendritic ligands via Sonogashira cross-coupling
The hydroxyl and alkenyl group are orthogonal in the Sonoga-
shira cross-coupling. The alkynyl group should be addressable
via a two-step protocol of a TMS-protected alkyne in a Sonoga-
shira cross-coupling and deprotection with K2CO3 in MeOH/
THF.[20] For the carboxyl group, a benzyl protected carboxylic
acid was introduced which may be removed by reduction with
H2/Pd.[21] First, alkyne 14a was obtained from undec-10-ynoic
acid and benzyl bromide in DMF with K2CO3 at ambient tem-
perature (not shown). After 1 day, the combined organic phase
was washed, dried with Na2SO4 and the solvent removed under
high vacuum to give reactant 14a in a yield of 95 %. Table 2
summarizes the results of the Sonogashira cross-coupling of
13b–13d with different alkynes 14a–14c, the reaction condi-
tions and the corresponding yields.
The bromides 13b and 13c led to the benzyl esters 15a and
15b in moderate yields, respectively. In the case of # 2, 49 % of
product 15b were obtained as a colorless solid and 19 % of
bromide 13c were recovered. An increase of the yield was ex-
pected with iodide 13d under similar conditions.[22] Indeed, the
reaction already took place at room temperature and monitor-
ing by thin layer chromatography indicated that the reaction
was completed after 3 h to give ester 15b in 84 % yield. If DMF
was replaced by toluene and used as solvent, the yield could
be further increased for 14b and 14c, respectively.[23] All prod-
ucts were obtained as pure compounds after purification with
column chromatography and showed good solubility in com-
mon organic solvents (e.g. halogenated solvents).
Deprotection of ester 15a was carried out with hydrogen
using Pd on charcoal as a catalyst to give the dendritic ligand
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Table 2. Results of the Sonogashira cross-coupling of halides 13b–13d with
different alkynes 14a–14c. Yields were determined after column chromatog-
raphy.
16 in quantitative yield (Scheme 4). In addition to the deprotec-
tion, the triple bond was also hydrogenated. In contrast, the
reduction of ester 15b bearing aromatic nitrile groups caused a
by-product (approx. 10 %). Unfortunately, this by-product could
Scheme 4. Reductive deprotection of ester 15a with H2/Pd results in the formation of dendritic ligand 16 in quantitative yield. As expected, the triple bond
was also hydrogenated to the single bond.
Eur. J. Org. Chem. 2019, 7820–7830 www.eurjoc.org © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim7823
neither be separated via column chromatographic purification
nor removed sufficiently via recrystallization.
It has been previously demonstrated that the reductive de-
protection with hydrogen and Pd works well alongside an aro-
matic nitrile group.[24] Using a Pd catalyst poisoned with Hünig′s
base, Mandle et al. succeeded in selectively reducing a triple
bond in the presence of an aromatic nitrile group, while the
aromatic nitrile was not reduced. Therefore, we investigated this
reduction initially using 18 (Scheme 5) as a model compound.
Starting from triflate 17[25] and benzyl ester 14a, the Pd-medi-
ated cross-coupling led by addition of lithium chloride (1.3
equivalent) to model compound 18. Without lithium chloride,
no cross-coupling was observed under the chosen reaction
conditions.[26]Then, 18 was hydrogenated exploiting the de-
scribed poisoned Pd catalyst (0.1 wt.-%) in methanol. After 12 h,
the 1H-NMR spectrum revealed the complete conversion of the
triple to the single bond – ester 19a was obtained (Scheme 5).
After 24 h, < 0.3 % of the ester group was deprotected. How-
ever, under these conditions, a reduction of the nitrile group to
the amine was also observed. Thus, this approach was not suit-
able for the selective deprotection of the benzyl group of ester
15b.
Therefore, an alternative strategy was developed in which a
terminal carboxyl anchoring group was introduced for dendritic
ligands bearing nitriles as end group of the (pro)mesogenic
unit. First, a Sonogashria cross-coupling under the same reac-
tion conditions as described before (GP-5) was performed with
iodide 13d and propargyl alcohol (20) yielding the dendritic
ligand 15e (Scheme 6). Ligand 15e is suitable for covalent cou-
pling to polymer-coated nanoparticles.[27] Second, we estab-
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Scheme 5. Synthesis of model compound 18 and its hydrogenation with a poisoned Pd(5 %/C) catalyst led to the selective hydrogenation of the triple bond.
The quantitative conversion to ester 19a was assigned via 1H NMR experiment.
Scheme 6. Synthesis of dendritic ligand 15e via Sonogashira cross-coupling.
Esterification of 15e and a) succinic anhydride (21a) and b) succinic acid
(21b) yielded dendritic ligand 2.
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lished a) an esterification[28] of dendritic ligand 15e and
succinic anhydride (21a) and b) a Steglich esterification[29] of
dendritic ligand 15e and succinic acid (21b). Both methods
gave the dendritic ligand 2 in excellent yields simply by wash-
ing the combined organic phases. The overall yield starting
from literature known triol 12b is 77 % (in the case of method
b). Since various dicarboxylic acids are commercially available,
it should be possible to obtain the corresponding dendritic li-
gands with different spacer lengths also in good overall yields.
Moreover, deprotection of 15d with K2CO3 in MeOH/THF
(1:1) yielded the dendritic ligand 23 (Scheme 7).[20] The
Scheme 7. Deprotection of silane 15d in a suspension of MeOH/THF (1:1)
and K2CO3 yielded the dendritic ligand 23.
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dendritic ligand 23 may be further exploited to functionalize
magnetic nanoparticles with (pro)mesogenic ligands via click
chemistry.[18]
Conclusions
In summary, we have shown the synthesis of various (pro)meso-
genic ligands with linear and dendritic structures using a Sono-
gashira cross-coupling reaction as a key step. Our approach rep-
resents a convenient and practical route which delivers the
(pro)mesogenic ligands in good overall yields, minimizes the
apparative effort and allows different end and anchoring
groups to be introduced, respectively. This is an important issue
with respect to the functionalization of MNPs in LC hosts and
the future application of the resulting hybrid materials. For in-
stance, the reductive deprotection of the benzyl ester 15a with
H2/Pd led to the quantitative formation of the dendritic ligand
16 with a carboxyl anchoring and an octyl end group. The den-
dritic ligand 15c with a terminal alkene was specifically de-
signed for the future functionalization of polymer-coated nano-
particles (i.e. via cross metathesis) and received with an overall
yield of 72 %. Moreover, the simple, three-step sequence of
etherification, Sonogashira cross-coupling and esterification
gave the (pro)mesogenic dendritic ligand 2 in an overall yield
of 77 %. The dendritic ligand 2 with nitrile end group was spe-
cifically tailored for the stabilization of MNPs in LC hosts (e.g.
5CB). The synthetic sequence is versatile and may be extended
to dendritic ligands with various spacer length and end groups.
This will allow for a systematic investigation of the relationships
between ligand structure and particle stability in LC matrices,
which will be a subject of our future investigations.
Experimental Section
General Remarks
All chemicals and reagents were obtained from commercial sources
and used as-received, unless otherwise noted. Dry solvents (i.e.,
acetone, dichloromethane, dimethylformamide, 1,3-dimethyl-2-
imidazolidinone, dimethyl sulfoxide, methanol, tetrahydrofuran,
toluene) were purchased from Sigma-Aldrich. Triethylamine and
ethylamine were dried and stored over 3 Å molecular sieves.[30]
Starting materials and reagents are purchased from commercial
sources: Bis(triphenylphosphine) palladium(II) dichloride (98 %,
Sigma-Aldrich), 16-bromo-hexadecanoic acid (99 %, Sigma-Aldrich),
11-bromoundecan-1-ol (99 %, abcr), 5-bromo-1,2,3-trimethoxy-
benzene (98 %, TCI), copper(I) iodide (98 %, abcr), dicyclohexyl-
carbodiimid (99 % abcr), diisopropyl azodicarboxylate (94 %, abcr),
4-dimethyl-aminopyridine (99 %, Sigma-Aldrich), hex-1-en-5-yne
(98 %, abcr), 4′-hydroxy-[1,1′-biphenyl]-4-carbonitrile (98 %, Alfa
Aesar), 4′-iodo-[1,1′-biphenyl]-4-ol (Alfa Aesar 98 %), 5-iodo-1,2,3-
trimethoxybenzene (98 %, Alfa Aesar), lithium bromide (99.9 %,
Sigma-Aldrich), lithium chloride (99.9 %, Sigma-Aldrich), methyl 7-
bromo-heptanoate (98 %, abcr), oct-1-yne (97 %, Alfa aesar), ω-
penta-decalactone (98 %, Sigma-Aldrich), potassium carbonate
(99 %, abcr), propargyl alcohol (99 %, Sigma-Aldrich), sodium
hydride (60 % dispersion, Sigma-Aldrich), succinic acid (99 %,
Sigma-Aldrich), succinic anhydride (99 % Arcos organics), trimethyl-
silylacetylene (98 % Arcos organics), triphenylphosphine (99 %
Sigma-Aldrich), undec-10-ynoic acid (95 %, Sigma-Aldrich). Manipu-
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lations under inert conditions were performed under an atmos-
phere of dry argon (6.0; Linde AG, Germany) using dry glassware
and syringe-cannula techniques which were argon flushed.
Analytical thin layer chromatography (TLC) was performed on TLC-
PET-sheets (pore size 60 Å, 25 μm). Components were visualized by
observation either under UV light (254 nm or 365 nm) or by dyeing
with KMnO4 solution. Flash column chromatography was carried
out using silica gel (pore size 60 Å, 40–63 μm) purchased from
Sigma Aldrich. Melting points (not corrected) were measured with
a Melting Point B-540 Büchi. 1H-NMR spectra were recorded at room
temperature on a Bruker Avance III 300 (250 MHz) and a Bruker
Avance III 400 (400 MHz). The spectra were recorded in CDCl3 and
d6-DMSO, respectively, as indicated in each case. Chemical shifts
(δ) were reported in parts per million (ppm) and referenced to the
remaining non-deuterated solvent signals of the deuterated sol-
vents.[31] The following abbreviations are used to indicate the signal
multiplicity: s (singlet), d (doublet), t (triplet), dd (doublet of dou-
blet), dt (doublet of triplet), b (broad signal), m (multiplet). All NMR
spectra were integrated and processed using the software
MestReNova. The coupling constants (J) are reported in Hertz. NMR
spectra are provided in the supporting information (SI). Accurate
mass spectra (MS) were determined at the MS facility of the Insti-
tute of Organic Chemistry, Heidelberg University. All ionization
methods (EI+, DART+, ESI–, MALDI+/–) were applied using following
mass spectrometers: Bruker FT-ICR Apex-Qe, Bruker AutoFlex Speed
TOF and JEOL JMS-700. The signal intensity of mass spectral peaks
is given relatively to the base peak intensity. IR spectra of the sam-
ples were recorded as pellets in potassium carbonate with the FT-
IR-spectrometer Varian 660-IR (Agilent Technologies, USA). The posi-
tion of the peaks is indicated in wavenumbers ν̃ in cm–1. The follow-
ing abbreviations are used to characterize the signals: s (strong), m
(medium), w (weak) and b (broad). Elementary analysis was deter-
mined using a vario MIKRO cube by Elementar.
Synthetic Procedures
Synthesis of Alkyne 4 via Sonogashira Cross-Coupling: Iodide 3
(1.00 g, 3.38 mmol), Pd(PPh3)2Cl2 (120 mg, 0.17 mmol), and copper
iodide (64.0 mg, 0.34 mmol) were added to a vial with a magnetic
stirrer bar and purged with argon. Then, degassed NEt3 (5 mL) and
1-octyne (550 μL, 411 mg, 3.73 mmol) were added and the reaction
mixture was stirred at 60 °C. After 2 d, Et2O (100 mL) was added
and the organic phase was washed with sat. NH4Cl solution and
brine. The combined organic phase was dried with CaCl2 and the
solvent was removed. After column chromatography (pentane/
EtOAc = 15:1) and removing the solvent under high vacuum,
834 mg (90 %) of alkyne 4 were obtained as an off-white solid. Rf =
0.23 (pentane/EtOAc, 15:1); m.p. 125 °C; 1H NMR (250 MHz, CDCl3):
δ = 7.53–7.39 (m, 6H, Ar-H), 6.96–6.84 (m, 2H, Ar-H), 4.88 (s, 1H,
-OH), 2.43 (t, 2H, 3JH,H = 7.0 Hz, C≡C-CH2), 1.64 (dd, 3JH,H = 15.0,
7.1 Hz, C≡CCH2-CH2), 1.55–1.41 (m, 2H, CH3CH2-CH2), 1.33 (dt, J =
7.0, 3.6 Hz, CH3-CH2), 0.98–0.85 (m, 3H, CH3). 13C NMR (63 MHz,
CDCl3): δ = 155.3, 139.8, 133.4, 132.0, 128.4, 126.5, 122.5, 115.8, 91.2,
80.6, 31.5, 28.9/28.8, 19.7, 14.2. IR (KBr): ν̃ = 3402 (bs), 3031 (w),
2954 (m), 2928 (m), 2856 (m), 1610 (m), 1597 (m), 1497 (m), 1467
(m), 1447 (m), 1403 (w), 1376 (m), 1302 (w), 1261 (m), 1116 (w),
1135 (w), 820 (s), 551 (w), 519 (m). MS (ESI, neg.): m/z calcd. for
C20H22O-H–: 277.1598, found 277.1597; elemental analysis calcd. (%)
for C20H2O: C 86.29 H 7.97; found C 86.17 H 7.81.
Pd-Catalyzed Hydration of Alkyne 4 to Alcohol 5: Palladium on
charcoal (10 % Pd/C, 185 mg) was added to a solution of alkyne 4
(700 mg, 3.38 mmol) in EtOAc (40 mL). The flask was charged with
H2 (10 % in argon) and the reaction mixture was vigorously stirred
at ambient conditions. After 15 h, Pd/C was filtered off and the
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solvent was removed by rotary evaporation. After column chroma-
tography (pentane/EtOAc = 10:1) and removing the solvent under
high vacuum, 673 mg (95 %) of alcohol 5 were obtained as colorless
solid. Rf = 0.49 (pentane/EtOAc, 10:1); m.p. 140 °C; 1H NMR
(250 MHz, CDCl3): δ = 7.54 – 7.40 (m, 4H, Ar-H), 7.26 – 7.18 (m, 2H,
Ar-H), 6.96 – 6.82 (m, 2H, Ar-3,5-H), 4.73 (s, 1H, OH), 2.63 (dd, 3JH,H =
8.8, 6.7 Hz, 2H, Ar-CH2), 1.73 – 1.54 (m, 2H, Ar-CH2-CH2), 1.43–1.22
(m, 10H, -(CH2)n), 2.94 (m, 3H, -CH3). 13C NMR (63 MHz, CDCl3): δ =
154.9, 141.7, 138.2, 134.2, 128.9, 128.3, 126.7, 115.7, 35.7, 32.1, 31.7,
29.7, 29.5, 29.4, 22.8, 14.3. IR (KBr): ν̃ = 3420 (bs), 3031 (w), 2957
(w), 2920 (m), 2848 (m), 1610 (m), 1501 (m), 1454 (w), 1378 (w),
1266 (m), 1245 (w), 814 (m), 785 (w), 506 (w). MS (ESI, neg.): m/z
calcd. for C20H26O-H–: 281.1911; found 281.1910; elemental analysis
calcd. (%) for C20H26O: C 85.06 H 9.28; found C 85.18 H 9.19.
Synthesis of Aliphatic Ligand 1: Mixture A: 16-bromohexa-decan-
oic acid (6) (781 mg, 2.33 mmol) and NaH (60 % dispersion in min-
eral oil, 98 mg, 2.45 mmol) were added to a solution of dry toluene
(25 mL) and dry DMSO (5 mL) and the reaction mixture was stirred
at room temperature. After 4.5 h, tetrabutylammonium sulfate
(38 mg, 0.11 mmol) was added and the reaction mixture was stirred
at 60 °C for 30 min. Mixture B: Alcohol 5 (625 mg, 2.22 mmol) and
NaH (60 % dispersion in mineral oil, 93 mg, 2.33 mmol) were added
to a solution of dry toluene (25 mL) and dry DMSO (5 mL) and the
mixture was stirred at RT. After 4 h, the reaction mixture was stirred
at 60 °C for 1 h. Then, mixture A was added to mixture B with a
syringe over a period of 30 min at 60 °C and after completion, the
reaction mixture was stirred vigorously at 80 °C. After 20 h, 1 M HCl
(30 mL) was added and the precipitate collected. The residue was
washed with H2O (2 × 10 mL), H2O/EtOH = 3:2 (6 mL) and dried
over-night under ambient conditions. The dry residue was sus-
pended in refluxing MeOH (50 mL) and collected after cooling to
ambient temperature. The white powder was suspended in CHCl3
(120 mL) and TFA was added until the product was dissolved. The
combined organic phase was washed with 1 M TFA (in H2O, 3 ×
10 mL), H2O (20 mL) and the solvent was removed by rotary evapo-
ration. Drying under high vacuum gave 965 mg (81 %) of aliphatic
ligand 1 as a colorless solid. Rf = 0.23 (pentane/EtOAc = 15:1); m.p.
125 °C; 1H NMR (250 MHz, CDCl3): δ = 7.53–7.42 (m, 4H, Ar-H), 7.22
(d, 3JH,H = 8.1 Hz, 2H, Ar-H), 6.95 (d, 3JH,H = 8.8, 2H, Ar-3,5-H), 3.99
(t, 3JH,H = 6.5 Hz, 2H, OCH2), 2.65–2.59 (m, 2H, Ar-CH2), 2.35 (d, J =
7.5 Hz, 2H, OCH2CH2), 1.78 (q, 3JH,H = 6.9 Hz, 2H, Ar-CH2-CH2), 1.64–
1.23 (m, 36H, -(CH2)n), 0.92–0.83 (m, 3H, -CH3). 13C NMR: could not
be measured due to poor solubility. IR (KBr): ν̃ = 3031 (w), 2917 (s),
2850 (m), 1700 (m), 1653 (m), 1608 (m), 1501 (m), 1473 (m), 1430
(m), 1282 (m), 1251 (m), 1202 (m), 1182 (m), 1043 (m), 997 (w),
911 (w), 806 (m), 718 (m), 669 (m). MS (ESI, neg.): m/z calcd. for
C36H56O3 – H–: 535.4157; found 535.4153; elemental analysis calcd.
(%) for C36H56O3: C 80.54 H 10.51; found C 80.37 H 10.57.
General Procedure for Mitsunobu Reaction (GP-1): Diisopropyl
azodicarboxylate (2.4 equiv.) was added under argon with a syringe
to a mixture of 11-bromoundecan-1-ol (8) (1.1 equiv.), alcohol
(1.0 equiv.), PPh3 (0.99 equiv.) and dry THF at 0 °C over a period of
20 min and after completion, the reaction mixture was allowed to
stirr at ambient temperature. After 3 d, the solvent was removed
under high vacuum. After column chromatography, washing with
ethanol and removing the solvent under high vacuum, the brom-
ides 9a–9c were obtained.
Bromide 9a: Using the general procedure GP-1, DIAD (5.0 mL,
5.15 g, 25.4 mmol), 11-bromoundecan-1-ol 8 (2.86 g, 11.4 mmol),
alkyne 4 (2.91 g, 10.4 mmol), PPh3 (2.97 g, 11.3 mmol) and THF
(24 mL) yielded 4.65 g (87 %) bromide 9a as weak yellow solid
after column chromatography (DCM/pentane = 3:5). Rf = 0.98 (DCM,
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stabilized with amylene); m.p. 82 °C; 1H NMR (250 MHz, CDCl3): δ =
7.56–7.40 (m, 6H, Ar-H), 7.01–6.90 (m, 2H, Ar-H), 3.99 (t, 3JH,H =
6.5 Hz, 2H), 3.41 (t, 3JH,H = 6.8 Hz, 2H), 2.42 (t, 3JH,H = 7.0 Hz, 2H),
1.83 (dt, 3JH,H = 14.1 Hz, 7.1 Hz, 2H), 1.69–1.55 (m, 2H), 1.45 (dt,
3JH,H = 10.4 Hz, 5.5 Hz, 6H), 1.39–1.22 (m, 22H, -CH2-), 0.98–0.84 (m,
3H). 13C NMR (63 MHz, CDCl3): δ = 159.0, 139.9, 132.0, 128.1, 126.5,
122.4, 114.9, 91.0, 80.6, 68.2, 34.2, 33.0, 31.5, 29.7, 29.6, 29.6, 29.5,
29.4, 28.9, 28.8, 28.3, 26.2, 22.7, 19.6, 14.2. IR (KBr): ν̃ = 2919 (bs),
2849 (m), 1609 (m), 1578 (w), 1529 (m), 1496 (m), 1476 (m), 1466
(m), 1437 (w), 1391 (w), 1293 (m), 1252 (m), 1197 (m), 1178 (m),
1030 (m), 1010 (m), 828 (s), 724 (m), 652 (m), 564 (w), 521 (m). MS
(DART, pos.): m/z calcd. for C31H43Br79 + H+: 511.2570; found
511.2574; elemental analysis calcd. (%) for C31H43BrO: C 72.78 H
8.47; found C 72.33 H 8.68.
Bromide 9b: Using the general procedure GP-1, DIAD (82.8 mg,
85 μL, 0.41 mmol), 11-bromoundecan-1-ol (8) (98.0 mg, 0.39 mmol),
alcohol 4 (100 mg, 0.35 mmol), PPh3 (102 mg, 0.39 mmol) and THF
(0.4 mL) yielded 171 mg (94 %) bromide 9b as colorless solid after
column chromatography (DCM stabilized with amylene). Rf = 0.80
(DCM, stabilized with amylene); m.p. 62–67 °C; 1H NMR (250 MHz,
CDCl3): δ = 7.48 (t, 3JH,H = 8.8 Hz, 4H, Ar-H), 7.29–7.16 (m, 2H,
Ar-H), 6.95 (d, 3JH,H = 8.5 Hz, 2H), 3.99 (t, 3JH,H = 6.4 Hz, 2H, OCH2),
3.41 (t, 3JH,H = 6.9 Hz, 2H, BrCH2), 2.63 (t, 3JH,H = 7.9 Hz, 2H, ArCH2),
1.92–1.75 (m, 4H, -CH2-), 1.71–1.58 (m, 2H, -CH2-), 1.56–1.22 (m, 22H,
-CH2-), 0.88 (t, 3JH,H = 7.9 Hz, -CH2-). 13C NMR (63 MHz, CDCl3): δ =
158.6, 141.5, 138.3 133.7, 128.0, 126.7, 114.8, 68.2, 35.7, 34.2, 33.0,
32.1, 31.7, 29.7, 29.6, 29.6, 29.5, 29.5, 29.4, 28.9, 28.3, 26.2, 22.8, 14.3.
IR (KBr): ν̃ = 2921 (s), 2851 (s), 1777 (w), 1647 (w), 1605 (m), 1582
(m), 1531 (w), 1501 (m), 1477 (m), 1463 (m), 1435 (w), 1397 (m),
1284 (m), 1270 (m), 1248 (m), 1213 (m), 1184 (m), 1139 (m), 1116
(m), 1039 (m), 861 (w), 814 (m), 782 (m), 723 (m), 651 (m), 592 (m),
509 (m), 491 (w). MS (DART, pos.): m/z calcd. for C31H47BrO + H+:
1048.5944; found 1048.5932; elemental analysis calcd. (%) for
C31H47BrO: C 72.21 H 9.19; found C 72.22 H 9.31.
Bromide 9c: Using the general procedure GP-1, DIAD (5.69 g,
5.52 mL, 28.1 mmol), 11-bromoundecan-1-ol (8) (7.08 g, 29.9 mmol),
alcohol 7 (.0 g, 25.6 mmol), PPh3 (7.39 g, 28.2 mmol) and THF
(20 mL) gave 10.9 g (99 %) bromide 9c as colorless solid after col-
umn chromatography (DCM stabilized with amylene). Rf = 0.80
(DCM, stabilized with amylene); m.p. 78 °C; 1H NMR (250 MHz,
CDCl3): δ = 7.67 (q, 3JH,H = 8.4 Hz, 4H, Ar-H), 7.58–7.47 (m, 2H,
Ar-H), 6.99 (d, 3JH,H = 8.3 Hz, 2H), 4.00 (t, 3JH,H = 6.6 Hz, 2H, OCH2),
3.41 (t, 3JH,H = 6.9 Hz, 2H, BrCH2), 1.91–1.74 (m, 4H, -CH2-), 1.54–
1.22 (m, 16H, -CH2-).
General Procedure for C(sp3)–C(sp3)-Negishi Cross-Coupling
(GP-2): A vial was charged with zinc powder (2.4 equiv.), iodine
(0.12 equiv.) and DMI and the mixture was stirred (slightly warmed).
After the brownish color disappeared, compound 10a–10b
(1.6 equiv.) was added under inert atmosphere and the reaction
mixture was stirred at 80 °C to give the corresponding organozinc
compound (ca. 1.0 M) after 3 h. A second vial was charged with
PEPPSI-IPr (1 mol-%), LiBr (1.6 equiv.) and dry THF and the mixture
was stirred. After a solution was formed, the organozinc compound
(1.6 equiv., 1.0 M in DMI) and bromide 9c (1 equiv.) were added.
The septum was replaced with a Teflon-lined screw cap under inert
atmosphere and the reaction was stirred for 1 d. After this time, the
mixture was diluted with THF (80 mL) and diethyl ether (40 mL)
and washed successively with Na3EDTA solution water, and brine.
After drying over Na2SO4, the solution was filtered and the solvent
removed in vacuo. After column chromatography (DCM; stabilized
with amylene) and removing the solvent under high vacuum, ester
11a–11b were obtained.
Full Paper
Ester 11a: Using the general procedure GP-2, zinc powder (79 mg,
1.2 mmol), iodine (10 mg, 0.06 mol), DMI (0.8 mL), methyl 7-bromo-
heptanoate (10a) (178 mg, 0.8 mmol), PEPPSI-IPr (3.4 mg,1 mol-%),
LiBr (139 mg, 0.8 mmol), dry THF (1.6 mL), bromide 9c (214 mg,
0.5 mmol) provided 157 mg (64 %) of ester 11a as colorless solid.
Rf = 0.47 (DCM, stabilized with amylene); m.p. 95 °C; 1H NMR
(250 MHz, CDCl3): δ = 7.72–7.61 (m, 4H, Ar-H), 7.52 (d, 3JH,H = 8.5 Hz,
2H, Ar-H), 7.99 (d, 3JH,H = 8.5 Hz, 2H, Ar-H), 4.00 (t, 3JH,H = 6.5 Hz,
2H, OCH2), 3.66 (s, 3H, CH3), 2.30 (t, 3JH,H = 7.6 Hz, 2H, CCH2), 1.81
(p, 3JH,H = 6.7 Hz, 2H, OCH2CH2), 1.61 (q, 3JH,H = 7.3 Hz, 2H, CCH2CH2),
1.51–1.42 (m, 2H, CCH2CH2), 1.41–1.10 (m, 28H, (CH2)n). 13C NMR
(100 MHz, CDCl3): δ = 174.5, 160.0, 145.5, 132.7, 131.4, 128.8, 127.2,
119.2, 115.3, 110.2, 68.4, 51.6, 34.3, 29.8, 29.8, 29.7, 29.6, 29.5, 29.4,
29.4, 29.3, 26.2, 25.1. IR (KBr): ν̃ = 2916 (s), 2849 (s), 2226 (m), 1723
(s), 1603 (m), 1498 (m), 1471 (m), 1435 (m), 1393 (m), 1328 (m), 1293
(m), 1268 (m), 1248 (s), 1214 (m), 1197 (m), 1119 (m), 1040 (m), 887
(w), 860 (w), 825 (s), 802 (m), 716 (m), 668 (m), 564 (m), 531 (m).
MS (DART, pos.): m/z calcd. for C32H45NO3 + NH4+: 509.3738; found
509.3737; elemental analysis calcd. (%) for C32H45NO3: C 78.17
H 9.22, N 2.85; found C 77.82 H 9.22 N 2.54.
Ester 11b: Using the general procedure GP-2, zinc powder (79 mg,
1.2 mmol), iodine (10 mg, 0.06 mol), DMI (0.8 mL), methyl 15-
bromopentadecanoate (10b) (178 mg, 0.8 mmol), PEPPSI-IPr
(3.4 mg,1 mol-%), LiBr (139 mg, 0.8 mmol), dry THF (1.6 mL), brom-
ide 9c (214 mg, 0.5 mmol) yielded 193 mg (63 %) ester 11a as
colorless solid. Rf = 0.55 (DCM, stabilized with amylene); m.p. 104 °C;
1H NMR (250 MHz, CDCl3): δ = 7.74–7.60 (m, 4H, Ar-H), 7.53 (d,
3JH,H = 8.7 Hz, 2H, Ar-H), 7.05–6.93 (m, Ar-H), 4.00 (t, 3JH,H = 6.5 Hz,
2H, OCH2), 3.66 (s, 3H, CH3, CH3), 2.30 (t, 3JH,H = 6.8 Hz, 2H, CCH2),
1.81 (p, 3JH,H = 6.8 Hz, 2H, OCH2CH2), 1.61 (t, 3JH,H = 6.5 Hz, 2H,
CCH2CH2), 1.25 (bs, 48H, (CH2)n). 13C NMR (63 MHz, CDCl3): δ =
132.7, 128.5, 127.2, 115.2, 111.2, 107.8, 97.4, 68.3, 51.6, 29.9 (m). IR
(KBr): ν̃ = 2916 (s), 2849 (s), 2226 (m), 1722 (m), 1603 (m), 1498 (m),
1472 (m), 1435 (m), 1393 (m), 1330 (w), 1289 (m), 1265 (m), 1249
(m), 1213 (m), 1186 (m), 1117 (w), 1043 (m), 999 (w), 886 (w), 825
(s), 717 (m), 668 (m), 568 (w), 531 (m). MS (DART, pos.): m/z calcd.
for C40H61NO3 + NH4+: 621.4990; found 621.4987; elemental analysis
calcd. (%) for C40H61NO3·CH2Cl2: C 79.55 H 10.18 N 2.32; found
C 75.49 H 9.83 1.73.
General Procedure for Etherfication (GP-3): Triol 12a–b
(1.0 equiv.), bromide 9a–c (3.5 equiv.), K2CO3 (35 equiv.) and tetra-
butylammonium hydrogensulfate (1 mol-%) were added under ar-
gon to dry acetone and the reaction mixture was stirred under
reflux. After 3 days, the residue was collected.
Iodide 13a: Using the general procedure GP-3, triol 12b (416 mg,
1.65 mmol), bromide 9a (3.00 g, 5.80 mmol), K2CO3 (2.30 g,
58.0 mmol) and tetrabutylammonium hydrogensulfate (5 mg), dry
acetone (40 mL) provided the crude product. After washing with
acetone (3 × 40 mL), ethanol (2 × 40 mL) and cyclohexane (2 ×
40 mL) the crude product was taken up onto Celite®. After column
chromatography (DCM/pentane = 3:5) and removing the solvent
under high vacuum 1.91 g (75 %) of iodide 13a were obtained as
colorless solid. Rf = 0.82 (DCM, stabilized with amylene); m.p. 109 °C,
1H NMR (250 MHz, CDCl3): δ = 7.56–7.38 (m, 18H, Ar-H), 6.94 (dd,
3JH,H = 8.8 Hz, 3.0 Hz, 6H, Ar-H), 6.84 (s, 2H, Ar-H), 4.09–3.82 (m,
12H, (OCH2)n), 2.42 (t, J = 7.0 Hz, 6H, C≡C-CH2) 1.77 (td, 3JH,H =
9.1 Hz, 4.4 Hz, 10H, (CH2)n), 1.66–1.53 (m, 64H, (CH2)n), 0.91 (td,
3JH,H = 6.8 Hz, 5.7 Hz, 2.9 Hz, 9H, -CH3). 13C NMR (63 MHz, CDCl3):
δ = 159.0, 154.1, 139.9, 132.9, 132.0, 128.1, 126.5, 122.4, 116.2, 114.9,
91.0, 80.6, 69.4, 68.2, 31.5, 30.4, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 28.9,
28.8, 26.2, 26.2, 22.7, 19.7, 14.2. IR (KBr): ν̃ = 3038 (w), 2920 (s), 2851
(m), 1607 (m), 1580 (m), 1528 (m), 1496 (m), 1468 (m), 1415 (m),
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1392 (m), 1287 (m), 1249 (m), 1197 (m), 1179 (m), 1121 (s), 1038
(m), 1000 (m), 822 (s), 721 (m), 653 (m), 567 (m), 521 (m), 479 (w),
331 (w). MS (MALDI, pos.): m/z calcd. for C99H131IO6+: 1543.9024;
found 1543.9026; elemental analysis calcd. (%) for C99H131IO6:
C 77.01 H 8.55, found: C 77.00 H 8.77.
Bromide 13b: Using the general procedure GP-3, triol 12a (315 mg,
2.50 mmol), bromide 9b (3.75 g, 8.75 mmol), K2CO3 (3.46 g,
25.0 mmol) and tetrabutylammonium hydrogensulfate (5 mg), dry
acetone (60 mL) provided the crude product. Then, DCM (600 mL)
was added, the combined organic phase was washed with water
(2 × 250 mL), brine (150 mL), dried with Na2SO4, Celite® was added
and the solvent was removed inhigh vacuum. After column chroma-
tography (DCM; stabilized with amylene) and removing the solvent
under high vacuum, 2.83 g (90 %) of bromide 13b were obtained
as colorless solid. Rf = 0.40 (DCM, stabilized with amylene); m.p.
121–122 °C; 1H NMR (250 MHz, CDCl3): δ = 7.71–7.59 (m, 12H, Ar-
H), 7.51 (dd, 3JH,H = 8.8 Hz, 3.0 Hz, 6H, Ar-H), 6.97 (dd, 3JH,H = 8.8 Hz,
3.8 Hz, 6H, Ar-H), 6.67 (s, 2H, Ar H), 4.04–3.87 (m, 12H, (OCH2)n),
1.86–1.67 (m, 12H, (CH2)n), 1.47 (s, 12H, (CH2)n), 1.31 (bs, 30H,
(CH2)n). 13C NMR (63 MHz, CDCl3): δ = 159.9, 153.9, 145.4, 137.4,
132.4, 131.4, 128.4, 127.2, 119.3, 115.7, 115.2, 110.2, 73.5, 69.4, 68.3,
30.4. 29.8, 29.8, 29.7, 29.7, 29.6, 29.5, 29.5, 29.4, 26.2, 26.2, 26.1. IR
(KBr): ν̃ = 2916 (s), 2850 (s), 2223 (m), 1603 (s), 1581 (m), 1521 (w),
1495 (s), 1473 (m), 1420 (m), 1391 (m), 1312 (w), 1291 (m), 1249 (s),
1180 (m), 1112 (m), 1035 (m), 998 (m), 819 (m), 718 (m), 560 (w),
530 (m). MS (DART, pos.): m/z calcd. for C78H92BrN3O6 + Na+:
1268.6067; found 1268.6062; elemental analysis calcd. (%) for
C78H92BrN3O6: C 75.10 H 7.34 N 3.37; found C 74.49 H 7.42 N 3.17.
Bromide 13c: Using the general procedure GP-3, triol 12a (985 mg,
3.91 mmol), bromide 9c (7.50 g, 17.5 mmol), K2CO3 (7.41 g,
53.6 mmol) and tetrabutylammonium hydrogensulfate (11 mg), dry
acetone (140 mL) provided the crude product. After washing with
acetone (2 × 80 mL) and EtOAc (2 × 80 mL), the crude product
was taken up onto Celite®. After column chromatography (DCM,
stabilized with amylene) and removing the solvent under high vac-
uum, 4.17 g (81 %) of bromide 13c were obtained as colorless solid.
Rf = 0.43 (DCM, stabilized with amylene); m.p. 126 °C; 1H NMR
(250 MHz, CDCl3): δ = 7.73–7.58 (m, 12H, Ar-H), 7.51 (dd, 3JH,H =
8.8 Hz, 2.0 Hz, 6H, Ar-H), 6.98 (dd, 3JH,H = 8.9 Hz, 2.5 Hz, 6H, Ar-H),
6.84 (s, 2H, Ar H), 4.12–3.75 (m, 12H, (OCH2)n), 1.78 (dp, 3JH,H =
15.2 Hz, 8.7 Hz, 7.7 Hz 12H, (CH2)n), 1.62–1.25 (m, 32H, (CH2)n). 13C
NMR (63 MHz, CDCl3): δ = 159.9, 154.0, 145.4, 138.4, 132.7, 131.3,
128.4, 127.2, 119.3, 116.2, 115.2, 110.1, 69.4, 68.3, 30.4, 29.8, 29.8,
29.7, 29.7, 29.6, 29.5, 29.5, 29.4, 29.4, 26.2, 26.2, 26.1. IR (KBr): ν̃ =
3042 (w), 2915 (s), 2850 (s), 2223 (m), 1734 (m), 1653 (w), 1603 (s),
1581 (m), 1521 (m), 1494 (s), 1473 (m), 1415 (m), 1395 (m), 1291
(m), 1249 (s), 1181 (m), 1110 (s), 1036 (m), 998 (m), 850 (m), 818 (s),
779 (m), 660 (w), 561 (m), 530 (m). Elemental analysis calcd. (%) for
C78H92IN3O6: C 72.37 H 7.16 N 3.32; found C 72.40 H 7.04 N 3.02.
Iodide 13d: Using the general procedure GP-3, triol 12b (177 mg,
0.86 mmol), bromide 9c (1.56 g, 3.02 mmol), K2CO3 (1.20 g,
30.2 mmol) and tetrabutylammonium hydrogensulfate (5 mg), dry
acetone (20 mL) provided the crude product under exclusion of
light. After washing with acetone/water (3:2) (100 mL) and EtOAc
(2 × 25 mL), the crude product was taken up onto Celite®. After
column chromatography (DCM, stabilized with amylene) and re-
moving the solvent under high vacuum, 1.07 g (82 %) of iodide 13d
were obtained as colorless solid. Rf = 0.81 (DCM/pentane, 3:5); m.p.
114 °C; 1H NMR (250 MHz, CDCl3): δ = 7.54–7.39 (m, 12H, Ar-H),
7.21 (d, 3JH,H = 7.9 Hz, 6H, Ar-H), 6.94 (dd, 3JH,H = 8.8 Hz, 2.4 Hz, 6H,
Ar-H), 6.67 (s, 2H, Ar H), 4.04–3.87 (m, 12H, (OCH2)n), 2.69–2.53 (m,
6H, Ar-CH2), 1.90–1.70 (m, 12H, (CH2)n), 1.71–1.58 (m, 6H, (CH2)n),
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1.52–1.12 (m, 12H, (CH2)n), 0.97–0.79 (m, 9H, CH3). 13C NMR
(63 MHz, CDCl3): δ = 158.6, 153.9, 141.5, 138.3, 137.4, 133.6, 128.9,
128.1, 126.7, 115.7, 114.8, 110.1, 35.7, 32.1, 31.7, 29.8, 29.7, 29.7,
29.6, 29.5, 29.4, 26.2, 26.2, 22.8. IR (KBr): ν̃ = 3030 (w), 2918 (s), 2850
(s), 1608 (s), 1583 (m), 1530 (w), 1501 (m), 1467 (m), 1422 (m), 1383
(m), 1253 (m), 1218 (m), 1180 (m), 1123 (m), 1040 (m), 1000 (m),
861 (m), 810 (m), 720 (m), 691 (w), 593 (w), 577 (w), 501 (w). MS
(MALDI, pos.): m/z calcd. for for C99H143BrO6 + H+: 1509.018; found
1509.005; elemental analysis calcd. (%) for C78H92BrN3O6: C 78.79
H 9.55; found C 78.32 H 9.66.
Synthesis of Alkyne 14a: Benzyl bromide (750 μL, 1078 mg,
6.30 mmol) was added dropwise at 0 °C to a mixture of undec-10-
ynoic acid (1092 mg, 6.00 mmol), anhydrous K2CO3 (1.24 g,
9.00 mmol) and dry DMF (9 mL) and after completion, the reaction
mixture was stirred at ambient temperature. After 1 day, ethyl acet-
ate (50 mL) was added and the combined organic phase was
washed with H2O (2 × 50 mL) and brine (2 × 50 mL) and dried
with Na2SO4. After removing the solvent under high vacuum, 1.49 g
(95 %) of alkyne 14a were obtained as yellow liquid. η(D/20) =
1.511; 1H NMR (250 MHz, CDCl3): δ = 7.35 (bs, 5H, Ar-H), 5.11 (s, 2H,
Bn-CH2), 2.34 (d, 3JH,H = 7.6 Hz, 2H, C≡C-CH2), 2.17 (td, 3JH,H = 7.0 Hz,
2.6 Hz, 2H, COO-CH2), 1.94 (t, 3JH,H = 7.6 Hz, 1H, C≡C-H), 1.66 (q,
3JH,H = 7.0 Hz, 6.4 Hz, 2H, COO-CH2-CH2), 1.50 (q, 3JH,H = 7.5 Hz, 2H,
C≡C-CH2-CH2), 1.45–1.19 (m, 8H, (-CH2-)n). 13C NMR (63 MHz,
CDCl3): δ = 173.8, 136.2, 128.7, 128.3, 84.9, 68.2, 66.2, 34.4, 29.2,
29.2, 29.0, 28.8, 28.6, 25.1, 18.5. IR (KBr): ν̃ = 3300 (m), 2932 (m),
2857 (m), 2117 (w), 1737 (s), 1587 (w), 1499 (m), 1461 (m), 1383 (m),
1352 (m), 1258 (m), 1235 (m), 1166 (m), 1099 (m), 1003 (m), 910
(m), 826 (w), 751 (m), 737 (m), 698 (m), 632 (m), 507 (m), 339 (m). MS
(EI, pos.): m/z calcd. for C18H24O2 + H+: 273.1849; found 273.1845;
elemental analysis calcd. (%) for C18H24O2: C 79.37 H 8.88; found
C 78.96 H 8.81.
General Procedure for the Sonogashria Cross-Coupling in DMF
(GP-4): Compound 13b–d (1.0 equiv.), Pd(PPh3)2Cl2 (35 mol-%),
copper iodide (38 mol-%) and a magnetic stirrer bar were added to
a vial and purged with argon. Then, degassed DMF, NEt3 and alkyne
14a (3.05 equiv.) were added and the reaction mixture was stirred.
After completion of the reaction, isopropyl alcohol was added. The
crude product was collected and washed with isopropyl alcohol.
Then, celite® and DCM was added and the solvent was removed.
Benzyl Ester 15a: Using the general procedure GP-4, bromide 13b
(532 mg, 353 μmol), Pd(PPh3)2Cl2 (88.0 mg, 125 μmol), copper iod-
ide (26.0 mg, 137 μmol), DMF (13 mL), NEt3 (3.5 mL) and benzyl
ester 14a (295 mg, 1.08 mmol) provided the crude product after
35 min at 90 °C. The amount of isopropyl alcohol was 100 mL and
30 mL. After column chromatography (DCM/pentane = 3:1) and re-
moving the solvent under high vacuum, 243 mg (40 %) of benzyl
ester 15a were obtained as a weak yellow solid. Rf = 0.34 (DCM/
pentane = 4:5); m.p. 83–86 °C; 1H NMR (250 MHz, CDCl3): δ = 7.47
(t, 3JH,H = 8.3 Hz, 12H, Ar-H), 7.35 (s, 5H, ArBn-H), 7.21 (s, 5H, d,
3JH,H = 8.4 Hz, 6H, Ar H), 7.00–6.87 (m, 6H, Ar H), 6.59 (s, Ar-H), 5.11
(s, 2H, OBn-CH2), 4.03–3.88 (m, 12H, O-CH2), 2.62 (t, 3JH,H = 7.6 Hz,
6H, Ar-CH2), 2.45–2.27 (m, 4H, (CH2)n), 1.93–1.69 (m, 12H, (CH2)n),
1.69–1.52 (m, 10H, (CH2)n), 1.52–1.07 (m, 84H, (CH2)n), 0.88 (t, 3JH,H =
6.4 Hz, 9H, -CH3). 13C NMR (63 MHz, CDCl3): δ = 173.8, 158.6, 141.5,
138.3, 133.6, 128.9, 128.1, 126.7, 118.6, 114.8, 35.7, 32.0, 29.7, 29.6,
29.5, 29.5, 29.4, 29.3, 29.2, 26.2, 22.8, 14.2. IR (KBr): ν̃ = 3030 (w),
2920 (s), 2851 (s), 1737 (m), 1608 (m), 1572 (m), 1530 (w), 1501 (s),
1466 (m), 1418 (m), 1384 (w), 1254 (m), 1121 (m), 1041 (m), 999 (w),
811 (m), 721 (m), 696 (m), 501 (m). MS (MALDI, pos.): m/z calcd. for
C117H166O8+: 1699.2577; found 1699.2577; elemental analysis calcd.
(%) for C117H166O8: C 82.63 H 9.84; found C 82.10 H 9.92.
Eur. J. Org. Chem. 2019, 7820–7830 www.eurjoc.org © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim7828
Benzyl Ester 15b: Using the general procedure GP-4, iodide 13d
(50.0 mg, 38 μmol), Pd(PPh3)2Cl2 (8.3 mg, 117 μmol), copper iodide
(2.6 mg, 13 μmol), DMF (1.2 mL), NEt3 (0.3 mL) and benzyl ester
14a (13.3 mg, 49.0 mmol) provided the crude product after 3 h at
room temperature. The amount of isopropyl alcohol was 10 mL
and 3 mL. After column chromatography (DCM) and removing the
solvent under high vacuum, 47 mg (84 %) of benzyl ester 15a were
obtained as a weak yellow solid. Rf = 0.47 (DCM); m.p. 78 °C; 1H
NMR (400 MHz, CDCl3): δ = 7.65 (q, 3JH,H = 8.4 Hz, 12H, Ar-H), 7.51
(d, 3JH,H = 8.7 Hz, 6H, Ar-H), 7.35 (s, 5H, ArBn-H), 6.98 (d, 3JH,H =
8.4 Hz, 6H, Ar-H), 6.59 (d, 3JH,H = 8.4 Hz, 2H, ArAlkyne-H), 5.11 (s,
2H, OBn-CH2), 4.07–3.84 (m, 12H, O-CH2), 2.41–2.29 (m, 4H, (CH2)n),
1.89–1.59 (m, 14H, (CH2)n), 1.56–1.18 (m, 52H, (CH2)n). 13C NMR
(63 MHz, CDCl3): δ = 159.9, 153.0, 145.4, 132.7, 131.4, 128.5, 127.2,
115.2, 110.2, 68.3, 34.4, 29.8, 29.7, 29.6, 29.5, 29.5, 29.4, 29.4, 26.2.
IR (KBr): ν̃ = 3030 (w), 2921 (m), 2851 (m), 2225 (m), 1742 (m), 1730
(m), 1604 (s), 1579 (m), 1524 (m), 1494 (m), 1468 (m), 1391 (m), 1353
(w), 1314 (w), 1290 (m), 1247 (s), 1181 (m), 1119 (s), 1031 (m), 1000
(m), 853 (m), 823 (s), 738 (m), 723 (m), 697 (w), 660 (m), 564 (m),
532 (m). MS (MALDI, pos.): m/z calcd. for C96H115N3O81 + H+:
1438.876; found 1438.868; elemental analysis calcd. (%) for
C96H115N3O81 1/6CH2Cl2: C 79.49 H 2.84 N 2.89; found C 79.25
H 8.09 N 2.56.
General Procedure for the Sonogashria Cross-Coupling in
Toluene (GP-5): Iodide 13d (1.0 equiv.), Pd(PPh3)2Cl2 (4.75 mol-%),
copper iodide (15.0 mol-%) were mixed, and, afterwards, degassed
toluene and a magnetic stirrer bar were added and purged with
argon. Then, HNEt2 and alkyne (14a–c) (5.0 equiv.) were added and
the reaction mixture was stirred at ambient conditions. After 20 h,
DCM (40 mL) were added and washed with saturated NH4Cl solu-
tion (2 × 40 mL) and brine (1 × 40 mL) and dried with Na2SO4. Then,
celite® was added and the solvent was removed. Column chromato-
graphic purification (DCM) gave the dendritic ligand 15c–e.
Dendritic Ligand 15c: Using the general procedure GP-4, iodide
13d (1.00 g, 772 μmol), Pd(PPh3)2Cl2 (22.0 mg, 36.7 μmol), copper
iodide (22.0 mg, 116 μmol), toluene (5.5 mL), HNEt2 (400 μL) hex-
1-en-5-yne (14b) (322 mg, 440 μL, 4.01 mmol) provided 865 mg
(89 %) of dendritic ligand 15c as a weak yellow waxy solid after
removing the solvent under high vacuum. Rf = 0.45 (DCM); m.p.
63 °C; 1H NMR (250 MHz, CDCl3): δ = 7.65 (q, 12H, 3JH,H = 8.2 Hz,
Ar-H), 7.51 (dd, 3JH,H = 8.8 Hz, 2.1 Hz, 6H, Ar-H ), 6.98 (d, 3JH,H =
8.7 Hz, 6H, Ar-H), 6.60 (s, 2H, Aralkyne-H), 6.02–5.80 (m, 1H, CH=
CH2), 5.19–4.99 (m, 2H, 1H, CH=CH2), 3.96 (dt, 3JH,H = 13.7 Hz, 12H,
OCH2), 1.81–1.56 (m, 4H, C-CH2-CH2), 1.91–1.62 (m, 12H, (CH2)n),
1.61–1.17 (m, 42H, (CH2)n). 13C NMR (63 MHz, CDCl3): δ = 159.9,
153.0, 145.4, 137.1, 132.7, 131.3, 128.4, 127.2, 119.3, 118.5, 115.8,
115.2, 110.1, 100.1, 88.3, 73.6, 69.1, 68.3, 33.1, 30.4, 29.8, 29.8, 29.7,
29.7, 29.6, 29.5, 29.5, 29.5, 29.4, 26.1, 19.4. IR (KBr): ν̃ = 3062 (w),
3042 (w), 2921 (m), 2851 (m), 2225 (m), 1604 (s), 1575 (m), 1521
(m), 1495 (s), 1473 (m), 1418 (m), 1390 (m), 1352 (w), 1290 (m), 1248
(s), 1180 (m), 1117 (m), 1033 (m), 1000 (m), 914 (w), 855 (m), 823
(s), 721 (w), 661 (w), 564 (m), 531 (m). MS (MALDI, pos.): m/z calcd.
for C84H99N3O6 + H+: 1246.7534; found 1246.7534; elemental analy-
sis calcd. (%) for C117H166O8: C 80.93 H 8.00 N 3.37; found C 80.64
H 7.99 N 3.08.
Dendritic Ligand 15d: Using the general procedure GP-4, iodide
13d (600 mg, 463 μmol), Pd(PPh3)2Cl2 (13.2 mg, 18.8 μmol), copper
iodide (13.2 mg, 69.3 μmol), toluene (3.3 mL), HNEt2 (240 μL) and
trimethyl-silylacetylene (14c) (322 mg, 440 μL, 4.01 mmol) provided
533 mg (90 %) of dendritic ligand 15d as colorless solid after re-
moving the solvent under high vacuum. Rf = 0.36 (DCM); m.p. 91 °C;
1H NMR (250 MHz, CDCl3): δ = 7.65 (q, 12H, 3JH,H = 8.2 Hz, Ar-H),
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7.75–7.59 (m, 12H, Ar-H), 7.51 (dd, 3JH,H = 8.8 Hz, 2.0 Hz, 6H, Ar-H ),
6.98 (d, 3JH,H = 8.9 Hz, 6H, Ar-H), 6.66 (s, 2H, Ar-alkyne-H), 4.06–3.81
(m, 12H, OCH2), 1.90–1.64 (m, 12H, (CH2)n), 1.45–1.15 (m, 42H,
(CH2)n), 0.24 (s, 9H, CH3). 13C NMR (63 MHz, CDCl3): δ = 159.9, 153.0,
146.1, 145.8, 145.4, 132.7, 131.4, 128.4, 127.2, 119.3, 117.6, 115.2,
110.5, 110.1, 73.6, 69.1, 68.3, 33.1, 30.4, 29.8, 29.8, 29.7, 29.6, 29.6,
29.5, 29.5, 29.4, 29.4, 26.2, 0.2. IR (KBr): ν̃ = 3039 (w), 2921 (m), 2852
(m), 2226 (m), 2150 (m), 1604 (m), 1576 (m), 1521 (m), 1495 (s), 1473
(m), 1419 (m), 1391 (m), 1340 (w), 1290 (m), 1248 (s), 1180 (m), 1118
(m), 1031 (m), 1000 (m), 822 (s), 759 (m), 721 (w), 661 (w), 634 (w),
564 (m), 531 (m). MS (MALDI, pos.): m/z calcd. for C83H101N3O6Si +
H+: 1264.7464; found 1264.7538; elemental analysis calcd. (%) for
C83H101N3O6Si: C 78.82 H 8.05 N 3.32; found C 78.58 H 8.21 N 3.11.
Dendritic Ligand 15e: Using the general procedure GP-4, iodide
13e (1.11 g, 859 μmol), Pd(PPh3)2Cl2 (25.0 mg, 42.8 μmol), copper
iodide (25.0 mg, 131 μmol), toluene (6 mL), HNEt2 (440 μL) and
propargyl alcohol (21) (250 mg, 260 μL, 428 μmol) provided 1.02 g
(97 %) of dendritic ligand 15e as colorless solid after removing the
solvent under high vacuum. 22 mg (2 %) of iodide 13d were recov-
ered. Rf = 0.42 (DCM); m.p. 103 °C; 1H NMR (250 MHz, CDCl3): δ =
7.77–7.57 (m, 12H, Ar-H), 7.55–7.42 (m, 6H), 6.98 (dd, 3JH,H = 8.9 Hz,
2.4 Hz, 6H, Ar-H), 6.64 (s, 2H, Ar-H), 4.47 (s, 2H, HO-CH2), 4.12–3.83
(m, 12H, OCH2), 1.91–1.62 (m, 14H, (CH2)n), 1.61–1.17 (m, 44H,
(CH2)n). 13C NMR (63 MHz, CDCl3): δ = 159.9, 153.0, 145.3, 139.2,
132.7, 131.3, 128.4, 127.1, 119.2, 117.1, 115.2, 110.3, 110.1, 86.1, 73.6,
69.2, 68.3, 51.7, 30.4, 29.8, 29.7, 29.7, 29.7, 29.5, 29.5, 29.4, 29.3, 26.2.
IR (KBr): ν̃ = 3451 (bm), 3042 (w), 2918 (m), 2850 (m), 2223 (m),
1603 (s), 1573 (m), 1523 (m), 1495 (s), 1468 (m), 1421 (m), 1390 (m),
1342 (m), 1291 (m), 1249 (s), 1181 (m), 1114 (m), 1055 (m), 1032
(m), 999 (m), 852 (m), 816 (s), 719 (w), 661 (w), 562 (m), 531 (m). MS
(MALDI, pos.): m/z calcd. for C81H95N3O7 + Na+: 1244.7068; found
1244.6340; elemental analysis calcd. (%) C81H95N3O7: C 79.57 H 7.83
N 3.44; found C 79.16 H 7.58 N 3.39.
Deprotection for Dendritic Ligand 16: Palladium on charcoal
(10 % Pd/C, 120 mg) was added to a solution of benzyl ester 15a
(150 mg, 88.0 μmol) in THF (70 mL). The flask was charged with H2
(10 % in argon) and the reaction mixture was vigorously stirred at
ambient conditions. After 12 h, Pd/C was filtered off and the solvent
was removed by rotary evaporation. After removing the solvent un-
der high vacuum, 142 mg (99 %) of dendritic ligand 16 were ob-
tained as colorless solid. M.p. 98–101 °C, 1H NMR (250 MHz, CDCl3):
δ = 7.53–7.40 (m, 12H, Ar-H), 7.21 (d, 6H, 3JH,H = 7.9 Hz, Ar-H), 6.93
(dd, 6H, 3JH,H = 8.8 Hz, 2.1 Hz, Ar-H), 6.36 (s, 2H Ar-H), 4.03–3.87 (m,
12H, O-CH2), 2.70–2.56 (m, 6H, Ar-CH2), 2.57–2.41 (m, 2H), 2.34 (t,
3JH,H = 7.5 Hz, 2H), 1.77 (h, 3JH,H = 6.1, 5.7 Hz, 12H, (CH2)n), 1.61 (q,
3JH,H = 7.5 Hz, 10H, (CH2)n), 1.54–1.12 (m, 90H, (CH2)n), 0.92–0.83 (m,
9H, -CH3). 13C NMR (63 MHz, CDCl3): δ = 189.9, 166.3, 161.3, 158.6,
157.0, 141.5, 138.3, 128.9, 128.0, 126.7, 114.8, 68.2, 35.7, 32.1, 31.7,
29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 26.2, 22.8, 14.3. IR (KBr): ν̃ = 3436
(bm), 3030 (w), 2919 (s), 2851 (s), 1708 (m), 1608 (m), 1583 (m),
1502 (m), 1466 (m), 1436 (m), 1384 (m), 1255 (m), 1214 (m), 1180
(m), 1121 (m),1043 (m), 812 (m), 722 (m), 593 (w), 500 (m). MS
(MALDI, neg.): m/z calcd. for C110H164O8 – H–: 1613.238; found
1613.234; elemental analysis calcd. (%) for C110H164O8 1/8CH2Cl2:
C 81.40 H 10.20, found: C 81.09 H 10.14.
Synthesis of Model Compound 18: Triflate 17 (327 mg,
1.00 mmol), Pd(PPh3)2Cl2 (47.0 mg, 67.0 μmol), copper iodide
(17.5 mg, 92.1 μmol), lithium chloride (55.1 mg, 1.3 mmol) and a
magnetic stirrer bar were added to a vial and purged with argon.
Then, degassed DMF (12.0 mL), NEt3 (3.0 mL) and benzyl ester 14a
(350 mg, 1.22 mmol) were added and the reaction mixture was
stirred at 85 °C. After 14 h, EtOAc (20 mL) was added at r.t., the
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combined organic phase was washed with sat. NH4Cl (4 × 20 mL)
and brine (2 × 20 mL) and dried with Na2SO4. The solved was re-
moved under vacuum. After column chromatography (pentane/
EtOAc = 10:1) and removing the solvent under high vacuum,
299 mg (67 %) of model compound 18 were obtained as a solid.
Rf = 0.70 (DCM); m.p. 34–42 °C; 1H NMR (400 MHz, CDCl3): δ = 7.77–
7.62 (m, 4H, Ar-H), 7.58–7.44 (m, 2H, Ar-H), 7.35 (s, 5H, ArBn-H), 5.11
(s, 2H, OBn-CH2), 2.42 (t, 3JH,H = 7.1 Hz, 2H, COO-CH2), 2.36 (t, 3JH,H =
7.5 Hz, 2H, ≡C-CH2), 1.63 (dt, 3JH,H = 15.0 Hz, 7.4 Hz, 2H, CH2), 1.50–
1.40 (m, 2H, CH2), 1.33 (s, 6H, CH2). 13C NMR (63 MHz, CDCl3): δ =
173.8, 136.2, 133.0, 132.8, 132.4, 129.3, 128.7, 128.3 128.0, 127.7,
127.1, 122.3, 92.5, 66.2, 35.1, 34.5, 29.3, 29.2, 29.1, 29.0, 28.8, 25.1,
19.6. IR (KBr): ν̃ = 3035 (w), 2931 (m), 2856 (m), 2227 (m), 1722 (m),
1605 (m), 1491 (m), 1468 (m), 1422 (m), 1391 (m), 1328 (w), 1247
(m), 1214 (m), 1170 (m), 1005 (w), 951 (m), 887 (m), 858 (m), 825
(s), 749 (m), 697 (m), 633 (m), 613 (m), 580 (m), 540 (m), 505 (w).
MS (DART, pos.): m/z calcd. for C32H33NO2 + H+: 450.2428; found
450.2427.
Synthesis of Dendritic Ligand 2: Method A: Dendritic ligand 15e
(679 mg, 555 μmol), succinic anhydride (21a) (76.6 mg, 765 μmol),
and DMAP (155 mg, 1.27 mmol) were solved in dry DCM (3.3 mL)
under argon and the reaction mixture was stirred at room tempera-
ture. After 1 day, DCM (70 mL) was added and the combined or-
ganic phase was washed with 0.5 M HCl solution (2 × 120 mL) and
water (100 mL). After removing the solvent under high vacuum,
719 mg (95 %) of dendritic ligand 2 were obtained as a colorless
solid. Method B: First, DMAP (51.5 mg, 442 μmol) was added to a
solution of succinic acid (21b) (24.0 mg, 203 μmol) and DCC
(8.9 mg, 43.1 μmol) in dry DCM/DMF = 1:1 (1 mL) under argon.
Second, dendron 15e (50.0 mg, 40.9 μmol) was added under argon
and the reaction mixture was stirred at room temperature. After 2
days, DCM (10 mL) was added and the combined organic phase
was washed with 0.5 M HCl solution (2 × 10 mL) and water (3 ×
10 mL). After removing the solvent under high vacuum, 53.1 mg
(98 %) of dendritic ligand 2 were obtained as a colorless solid. M.p.
88–95 °C; 1H NMR (250 MHz, CDCl3): δ = 7.78–7.56 (m, 12H, Ar-H),
7.51 (dd, 3JH,H = 8.8 Hz, 3JH,H = 1.9 Hz, 6H), 6.98 (dd, 3JH,H = 8.8 Hz,
2.4 Hz, 6H, Ar-H), 6.65 (s, 2H, Ar-H), 4.13–3.80 (m, 12H, OCH2), 2.71
(s, 4H, COO-CH2), 1.91–1.62 (m, 12H, (CH2)n), 1.61–1.17 (m, 42H,
(CH2)n). 13C NMR (63 MHz, CDCl3): δ = 176.6, 171.6, 159.9, 153.0,
145.4, 132.7, 131.4, 128.4, 127.2, 119.2, 116.5, 115.2, 110.6, 110.2,
87.1, 81.5, 73.6, 69.2, 68.3, 53.4, 30.4, 29.8, 29.8, 29.7, 29.7, 29.6, 29.5,
29.5, 29.4, 29.4, 29.4, 28.8, 28.7, 26.2. IR (KBr): ν̃ = 3040 (w), 2923
(m), 2852 (m), 2225 (m), 1742 (m), 1713 (m), 1604 (m), 1577 (m),
1523 (m), 1495 (m), 1468 (m), 1420 (m), 1389 (m), 1337 (m), 1291
(m), 1250 (s), 1180 (m), 1115 (m), 1065 (m), 1031 (m), 1000 (m), 966
(m), 821 (s), 722 (m), 660 (m), 633 (m), 563 (m), 532 (m). MS (MALDI,
neg.): m/z calcd. for C85H99N3O10 – H–: 1320.7258; found 1320.7272;
elemental analysis calcd. (%) C85H99N3O10: C 77.18 H 7.54 N 3.18;
found C 76.91 H 7.82 N 3.13.
Synthesis of Dendritic Ligand 23: Silane 15e (385 mg, 0.30 mmol)
and K2CO3 (150 mg, 1.09 mmol) were added to dry MeOH/THF =
1:1 (20 mL) and the reaction mixture was stirred at room tempera-
ture. After 3.5 h, n-hexane (50 mL) was added and the precipitate
was collected. The combined organic phase was washed with
MeOH (50 mL). After column chromatography (DCM, stab. with am-
ylene) and removing the solvent under high vacuum, 349 mg (96 %)
of dendritic ligand 23 were obtained as a colorless solid. Rf = 0.29
(DCM, stab. with amylene); m.p. 62 °C; 1H NMR (250 MHz, CDCl3):
δ = 7.80–7.58 (m, 12H, Ar-H), 7.51 (dd, 3JH,H = 8.8 Hz, J = 2.0 Hz,
6H), 6.98 (dd, 3JH,H = 8.8 Hz, 2.4 Hz, 6H, Ar-H), 6.69 (s, 2H, Ar-H),
4.09–3.81 (m, 12H, OCH2), 3.00 (s, 1H, C-H), 1.92–1.64 (m, 12H,
(CH2)n), 1.55–1.14 (m, 42H, (CH2)n). 13C NMR (63 MHz, CDCl3): δ =
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159.9, 153.0, 145.4, 139.5, 132.7, 131.3, 128.4, 127.2, 119.3, 116.5,
115.2, 110.7, 100.1, 91.7, 84.1, 73.6, 69.2, 68.3, 30.4, 29.8, 29.8, 29.7,
29.6, 29.5, 29.5, 29.4, 29.4, 29.4, 26.2. IR (KBr): ν̃ = 3236 (m), 3042
(w), 2916 (m), 2850 (m), 2224 (m), 1603 (s), 1578 (m), 1524 (m), 1495
(s), 1474 (m), 1421 (m), 1391 (m), 1333 (m), 1291 (m), 1249 (s), 1181
(m), 1113 (m), 1037 (m), 999 (m), 851 (m), 819 (m), 718 (m), 661
(m), 632 (m), 562 (m), 531 (m). MS (MALDI, neg.): m/z calcd. for
C80H93N3O6+: 1192.7143; found 1192.7086; elemental analysis calcd.
(%) C80H93N3O6: C 80.57 H 7.86 N 3.52; found C 80.47 H 7.95 N 3.16.
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